Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.007 par value
-
Shares outstanding
-
2,027,012
-
Total 13F shares
-
276,856
-
Share change
-
+276,856
-
Total reported value
-
$819,496
-
Price per share
-
$2.96
-
Number of holders
-
12
-
Value change
-
+$819,496
-
Number of buys
-
12
Institutional Holders of bioAffinity Technologies, Inc. - Common Stock, $0.007 par value (BIAF) as of Q3 2025
As of 30 Sep 2025,
bioAffinity Technologies, Inc. - Common Stock, $0.007 par value (BIAF) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
276,856 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, Scientech Research LLC, VANGUARD GROUP INC, Tower Research Capital LLC (TRC), Allworth Financial LP, BANK OF AMERICA CORP /DE/, IFP Advisors, Inc, UBS Group AG, CITIGROUP INC, and Larson Financial Group LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.